There is as yet no functional evidence of a link between MAP2K4 and protection against EBV infection or NPC development, only reports of increased MAP2K4 expression in EBV-positive T and NK lymphoma-derived cell lines [84]. This evidence concerns the gene MAP2K4 and nasopharyngeal carcinoma.